Apolipoprotein E inhibits the depolymerization of β2-microglobulin-related amyloid fibrils at a neutral pH

被引:63
作者
Yamaguchi, I
Hasegawa, K
Takahashi, N
Gejyo, F
Naiki, H [1 ]
机构
[1] Fukui Med Univ, Dept Pathol, Fukui 9101193, Japan
[2] Niigata Univ, Sch Med, Dept Med 2, Niigata 9518510, Japan
关键词
D O I
10.1021/bi0027128
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta2-Microglobulin-related (A beta 2M) amyloidosis is a common and serious complication in patients on long-term hemodialysis, and beta2-microglobulin (beta2-m) is a major structural component of A beta 2M amyloid fibrils. Fluorescence spectroscopic analysis with thioflavin T and electron microscopic study revealed that A beta 2M amyloid fibrils readily depolymerize into monomeric beta2-m at a neutral to basic pH. Circular dichroism analysis revealed that soon after the initiation of the depolymerization reaction at pH 7.5, the characteristic spectrum of beta2-m in A beta 2M amyloid fibrils changes to resemble that of monomeric beta2-m at pH 7.5. Apolipoprotein E (apoE), a representative amyloid-associated protein, formed a stable complex with A beta 2M amyloid fibrils and inhibited the depolymerization of A beta 2M amyloid fibrils dose-dependently in a range of 0-10 muM. These results showed that apoE could enhance the deposition of amyloid fibrils in vivo, possibly by binding directly to the surface of the fibrils and stabilizing the conformation of beta2-m in the fibrils.
引用
收藏
页码:8499 / 8507
页数:9
相关论文
共 58 条
[31]  
Kindy MS, 1998, AM J PATHOL, V152, P1387
[32]   DIALYSIS-RELATED AMYLOIDOSIS [J].
KOCH, KM ;
GENNARI, FJ ;
VANYPERSELE, C ;
REES, A ;
GOLDMAN, M ;
MIHATSCH, MJ ;
MION, CM ;
BORSATTI, A ;
WINEARLS, CG ;
DAVISON, AM ;
COHEN, JJ ;
MADIAS, NE ;
OLMER, M ;
HARRINGTON, JT ;
BAGGIO, B ;
RAMBAUSEK, MH ;
DONOHOE, JF ;
VANES, LA .
KIDNEY INTERNATIONAL, 1992, 41 (05) :1416-1429
[33]   AMYLOID-ASSOCIATED PROTEINS ALPHA(1)-ANTICHYMOTRYPSIN AND APOLIPOPROTEIN-E PROMOTE ASSEMBLY OF ALZHEIMER BETA-PROTEIN INTO FILAMENTS [J].
MA, JY ;
YEE, A ;
BREWER, HB ;
DAS, S ;
POTTER, H .
NATURE, 1994, 372 (6501) :92-94
[34]   REVERSIBLE INVITRO GROWTH OF ALZHEIMER-DISEASE BETA-AMYLOID PLAQUES BY DEPOSITION OF LABELED AMYLOID PEPTIDE [J].
MAGGIO, JE ;
STIMSON, ER ;
GHILARDI, JR ;
ALLEN, CJ ;
DAHL, CE ;
WHITCOMB, DC ;
VIGNA, SR ;
VINTERS, HV ;
LABENSKI, ME ;
MANTYH, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5462-5466
[35]  
MARLEY RW, 1988, SCIENCE, V240, P622
[36]   Partially unfolded states of β2-microglobulin and amyloid formation in vitro [J].
McParland, VJ ;
Kad, NM ;
Kalverda, AP ;
Brown, A ;
Kirwin-Jones, P ;
Hunter, MG ;
Sunde, M ;
Radford, SE .
BIOCHEMISTRY, 2000, 39 (30) :8735-8746
[37]   Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's β-amyloid fibril formation in vitro [J].
Naiki, H ;
Hasegawa, K ;
Yamaguchi, I ;
Nakamura, H ;
Gejyo, F ;
Nakakuki, K .
BIOCHEMISTRY, 1998, 37 (51) :17882-17889
[38]   Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro [J].
Naiki, H ;
Hashimoto, N ;
Suzuki, S ;
Kimura, H ;
Nakakuki, K ;
Gejyo, F .
AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1997, 4 (04) :223-232
[39]   Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro [J].
Naiki, H ;
Gejyo, F ;
Nakakuki, K .
BIOCHEMISTRY, 1997, 36 (20) :6243-6250
[40]  
Naiki H, 1996, LAB INVEST, V74, P374